In conjunction with the previously provided “Notice of Approval for Re‑Registration of Chemical Active Pharmaceutical Ingredients,” this new document, the “Notification on GMP Compliance Inspection for Pharmaceuticals,” further strengthens Jiangsu Shuanglin Marine Bio‑Pharmaceutical Co., Ltd.’s compliance barriers and quality endorsement for the product “Glucosamine Sulfate Potassium Chloride.”
The following are the core points of this notice and an analysis of its added value when combined with the re-registration approval:
1. File Basic Information
Document Type: Official Notification of GMP Compliance Inspection Results (No.: Su Yao Jian Yao Sheng Gao Zhi (2026) No. 079).
Issuing Authority: Jiangsu Provincial Drug Administration.
Date of Issuance: March 9, 2026.
2. Check the core content.
Inspected entity: Jiangsu Shuanglin Marine Bio‑Pharmaceutical Co., Ltd.
Inspection Address: No. 40, Lvdong Street, Lüsi Marine Economic Development Zone, Jiangsu (completely consistent with the address on the re‑registration approval document, indicating that the production site has not changed and remains stable).
Scope of Inspection: Active Pharmaceutical Ingredient (Glucosamine Sulfate Potassium Chloride).
Specific production line: Raw Material Pharmaceutical Workshop in Building 2, Glucosamine Sulfate Potassium Chloride (clearly designated as a dedicated workshop/production line).
Inspection Basis: Good Manufacturing Practice for Pharmaceutical Products (Revised in 2010).
Inspection period: December 19, 2025 – December 21, 2025.
Conclusion: Meets the requirements.
3. Core Value Analysis (Synergies with the Re-registration Approval)
If the re‑registration approval addresses the legal “can we sell?” question, then this GMP Notification resolves the quality compliance issue of “can we manufacture?”

4. Summary
This GMP notification is the “perfect partner” for the previous re-registration approval:
Identity + Quality: Re-registration gave it “household registration,” while GMP awarded it a “Certificate of Excellent Quality Inspection.”
For customers: Upon reviewing these two documents, it’s safe to say that Jiangsu Shuanglin is one of the most compliant and reliable suppliers for this product.
For businesses: Before 2031, as long as no major changes or recalls occur, all regulatory hurdles for the production and sale of this product will have been cleared.
One additional point: The bottom of the notice mentions the rights to file for administrative reconsideration and administrative litigation. This is a standard administrative notification procedure, indicating that the document is formal and traceable, with no procedural defects whatsoever.